Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy.

Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy.

Oncotarget. 2018 Mar 30;9(24):17256

Authors: Gritt G, Gianatt A, Petronzeii F, De Santis R, Pavoni C, Rossi RL, Cattaneo L, Spagnoli LG, Ferrar S, Ross A, Barbu AM, Rambald A

Abstract
[This corrects the article DOI: 10.18632/oncotarget.23919.].

PMID: 29683132 [PubMed - in process]

https://ift.tt/2HpyRW1